Sacramento (1)

Metastatic Pancreatic Adenocarcinoma (1)

Refractory Pancreatic Adenocarcinoma (1)

Stage IV Pancreatic Cancer AJCC v8 (1)

Active, not recruiting (1)

phase 1 (1)

University of California, Davis (1)

Bristol-Myers Squibb (1)

Dynavax Technologies Corporation (1)

National Cancer Institute (NCI) (1)

nivolumab (1)

radiation therapy (1)

tlr9 agonist sd-101 (1)

biological (1)

drug (1)

radiation (1)

Other (1)

Interventional (1)

refractory pancreatic adenocarcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Sacramento, California

University of California Davis Comprehensive Cancer Center

Dec 16, 2021